Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paroxysmal non-kinesigenic dystonia.

S B Bressman1, S Fahn, R E Burke

  • 1Department of Neurology, Columbia University, College of Physicians and Surgeons, New York, New York 10032.

Advances in Neurology
|January 1, 1988
PubMed
Summary

This study identified three subgroups of paroxysmal nonkinesigenic dystonia: primary sporadic, psychogenic, and symptomatic. Clonazepam and acetazolamide showed effectiveness in managing patient symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Frailty on Gait Speed Improvements in Home Health after Hospital Discharge: Secondary Analysis of Two Randomized Controlled Trials.

The Journal of frailty & aging·2024
Same author

Cognitive and Antipsychotic Medication Use in Monoallelic GBA-Related Parkinson Disease.

JIMD reports·2014
Same author

Quantitative morphological comparison of axon-targeting strategies for gene therapies directed to the nigro-striatal projection.

Gene therapy·2013
Same author

Transcranial sonography and functional imaging in glucocerebrosidase mutation Parkinson disease.

Parkinsonism & related disorders·2012
Same author

Variant ataxia-telangiectasia presenting as primary-appearing dystonia in Canadian Mennonites.

Neurology·2012
Same author

Gender differences in the IL6 -174G>C and ESR2 1730G>A polymorphisms and the risk of Parkinson's disease.

Neuroscience letters·2011

Area of Science:

  • Neurology
  • Movement Disorders

Background:

  • Paroxysmal nonkinesigenic dystonia (PND) is a rare movement disorder characterized by involuntary muscle contractions.
  • Understanding the diverse etiologies and clinical presentations of PND is crucial for effective diagnosis and management.

Purpose of the Study:

  • To categorize patients with PND based on etiology.
  • To compare clinical characteristics of sporadic PND with previously reported familial cases.
  • To evaluate the efficacy of certain medications in treating PND.

Main Methods:

  • Retrospective review of medical records of 25 patients diagnosed with PND at a Dystonia Clinical Research Center.
  • Classification of patients into three etiological subgroups: primary sporadic, psychogenic, and symptomatic.
  • Analysis of clinical features, including age of onset, sex distribution, attack frequency, and duration.
  • Assessment of treatment response to clonazepam and acetazolamide.

Main Results:

  • Three distinct subgroups were identified: primary sporadic (7 patients), psychogenic (11 patients), and symptomatic (7 patients).
  • No cases of primary paroxysmal dystonia with a family history were found.
  • Sporadic cases exhibited differences from familial PND, including adult onset, female predominance, and variable attack characteristics.
  • Some patients showed overlapping features with paroxysmal kinesigenic choreoathetosis (PKC).
  • Clonazepam and acetazolamide were effective in managing symptoms for several patients.

Conclusions:

  • PND presents with diverse etiologies, necessitating subgroup classification for better understanding.
  • Sporadic PND has distinct clinical features compared to familial forms.
  • Pharmacological interventions like clonazepam and acetazolamide can be beneficial in managing PND symptoms.

Related Experiment Videos